https://milkeninstitute.org/philanthropy/science-philanthropy-accelerator-research-and-collaboration-sparc/oncology/advancing-precision-medicine-uterine-leiomyosarcoma
Advancing Precision Medicine in Uterine Leiomyosarcoma | Milken Institute
Uterine leiomyosarcoma (uLMS) is a rare, aggressive cancer in the uterus. It typically affects women between 45 and 60, often during perimenopause.
precision medicineuterine leiomyosarcomaadvancingmilkeninstitute